Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

Is Insulet Stock Underperforming the Nasdaq?

Acton, Massachusetts-based Insulet Corporation (PODD) is a medical technology company that specializes in innovative insulin delivery solutions for people with diabetes. Valued at a market cap of $20.5 billion, the company is best known for its Omnipod® Insulin Management System, a tubeless, wearable insulin pump that delivers continuous insulin without the need for external tubing. 

Companies valued at $10 billion or more are typically classified as “large-cap stocks,” and PODD fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the medical devices industry. The company primarily serves individuals with Type 1 diabetes and insulin-dependent Type 2 diabetes, and its technology-driven, recurring-revenue model positions it as a key player in the global diabetes care market.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.